Annual Cash & Cash Equivalents
$82.00 M
+$16.05 M+24.34%
December 31, 2023
Summary
- As of February 12, 2025, MDXG annual cash & cash equivalents is $82.00 million, with the most recent change of +$16.05 million (+24.34%) on December 31, 2023.
- During the last 3 years, MDXG annual cash & cash equivalents has fallen by -$13.81 million (-14.42%).
- MDXG annual cash & cash equivalents is now -14.42% below its all-time high of $95.81 million, reached on December 31, 2020.
Performance
MDXG Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$88.80 M
+$19.76 M+28.63%
September 30, 2024
Summary
- As of February 12, 2025, MDXG quarterly cash and cash equivalents is $88.80 million, with the most recent change of +$19.76 million (+28.63%) on September 30, 2024.
- Over the past year, MDXG quarterly cash and cash equivalents has increased by +$40.31 million (+83.14%).
- MDXG quarterly cash and cash equivalents is now -18.97% below its all-time high of $109.59 million, reached on September 30, 2020.
Performance
MDXG Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MDXG Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +24.3% | +83.1% |
| 3 y3 years | -14.4% | +17.3% |
| 5 y5 years | +81.8% | +28.6% |
MDXG Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -5.8% | +24.3% | at high | +83.1% |
| 5 y | 5-year | -14.4% | +24.3% | -19.0% | +84.3% |
| alltime | all time | -14.4% | >+9999.0% | -19.0% | >+9999.0% |
MiMedx Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $88.80 M(+28.6%) |
| Jun 2024 | - | $69.04 M(+42.4%) |
| Mar 2024 | - | $48.49 M(-40.9%) |
| Dec 2023 | $82.00 M(+24.3%) | $82.00 M(+1.0%) |
| Sep 2023 | - | $81.16 M(+18.2%) |
| Jun 2023 | - | $68.65 M(+12.1%) |
| Mar 2023 | - | $61.22 M(-7.2%) |
| Dec 2022 | $65.95 M(-24.3%) | $65.95 M(-9.9%) |
| Sep 2022 | - | $73.22 M(+1.0%) |
| Jun 2022 | - | $72.50 M(-4.2%) |
| Mar 2022 | - | $75.68 M(-13.1%) |
| Dec 2021 | $87.08 M(-9.1%) | $87.08 M(-3.9%) |
| Sep 2021 | - | $90.61 M(+6.6%) |
| Jun 2021 | - | $85.01 M(+0.3%) |
| Mar 2021 | - | $84.75 M(-11.5%) |
| Dec 2020 | $95.81 M(+38.7%) | $95.81 M(-12.6%) |
| Sep 2020 | - | $109.59 M(+127.4%) |
| Jun 2020 | - | $48.19 M(-10.0%) |
| Mar 2020 | - | $53.52 M(-22.5%) |
| Dec 2019 | $69.07 M(+53.1%) | $69.07 M(-26.6%) |
| Sep 2019 | - | $94.12 M(-2.9%) |
| Jun 2019 | - | $96.93 M(+241.5%) |
| Mar 2019 | - | $28.38 M(-37.1%) |
| Dec 2018 | $45.12 M(+64.2%) | $45.12 M(+64.2%) |
| Dec 2017 | $27.48 M(-20.1%) | $27.48 M(-24.8%) |
| Sep 2017 | - | $36.52 M(-23.2%) |
| Jun 2017 | - | $47.53 M(+53.7%) |
| Mar 2017 | - | $30.92 M(-10.1%) |
| Dec 2016 | $34.39 M(+20.7%) | $34.39 M(+87.5%) |
| Sep 2016 | - | $18.34 M(-23.0%) |
| Jun 2016 | - | $23.80 M(+57.5%) |
| Mar 2016 | - | $15.12 M(-46.9%) |
| Dec 2015 | $28.49 M | $28.49 M(-30.6%) |
| Sep 2015 | - | $41.07 M(+6.4%) |
| Jun 2015 | - | $38.60 M(-0.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $38.70 M(-16.9%) |
| Dec 2014 | $46.58 M(+5.7%) | $46.58 M(-1.4%) |
| Sep 2014 | - | $47.25 M(+20.4%) |
| Jun 2014 | - | $39.25 M(-8.8%) |
| Mar 2014 | - | $43.02 M(-2.4%) |
| Dec 2013 | $44.08 M(+552.6%) | $44.08 M(+627.1%) |
| Sep 2013 | - | $6.06 M(+44.5%) |
| Jun 2013 | - | $4.19 M(-26.8%) |
| Mar 2013 | - | $5.73 M(-15.2%) |
| Dec 2012 | $6.75 M(+64.3%) | $6.75 M(-11.4%) |
| Sep 2012 | - | $7.62 M(+187.1%) |
| Jun 2012 | - | $2.65 M(-12.1%) |
| Mar 2012 | - | $3.02 M(-26.5%) |
| Dec 2011 | $4.11 M(+206.7%) | $4.11 M(+545.4%) |
| Sep 2011 | - | $637.20 K(-60.5%) |
| Jun 2011 | - | $1.61 M(+58.2%) |
| Mar 2011 | - | $1.02 M(-23.9%) |
| Dec 2010 | $1.34 M(-49.5%) | $1.34 M(+212.9%) |
| Sep 2010 | - | $428.50 K(-84.3%) |
| Jun 2010 | - | $2.73 M(+67.6%) |
| Mar 2010 | - | $1.63 M(>+9900.0%) |
| Dec 2009 | $2.65 M(+7525.0%) | - |
| Sep 2009 | - | $5800.00(-99.6%) |
| Jun 2009 | - | $1.62 M(+4557.8%) |
| Mar 2009 | - | $34.80 K(-96.0%) |
| Mar 2009 | $34.80 K(-99.5%) | - |
| Dec 2008 | - | $864.80 K(-63.2%) |
| Sep 2008 | - | $2.35 M(-39.4%) |
| Jun 2008 | - | $3.88 M(>+9900.0%) |
| Mar 2008 | $6.75 M(>+9900.0%) | - |
| Dec 2007 | $200.00(-96.9%) | $200.00(-85.7%) |
| Sep 2007 | - | $1400.00(-90.5%) |
| Jun 2007 | - | $14.70 K(+716.7%) |
| Mar 2007 | - | $1800.00 |
| Dec 2006 | $6400.00 | - |
FAQ
- What is MiMedx annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for MiMedx?
- What is MiMedx annual cash & cash equivalents year-on-year change?
- What is MiMedx quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for MiMedx?
- What is MiMedx quarterly cash and cash equivalents year-on-year change?
What is MiMedx annual cash & cash equivalents?
The current annual cash & cash equivalents of MDXG is $82.00 M
What is the all time high annual cash & cash equivalents for MiMedx?
MiMedx all-time high annual cash & cash equivalents is $95.81 M
What is MiMedx annual cash & cash equivalents year-on-year change?
Over the past year, MDXG annual cash & cash equivalents has changed by +$16.05 M (+24.34%)
What is MiMedx quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of MDXG is $88.80 M
What is the all time high quarterly cash and cash equivalents for MiMedx?
MiMedx all-time high quarterly cash and cash equivalents is $109.59 M
What is MiMedx quarterly cash and cash equivalents year-on-year change?
Over the past year, MDXG quarterly cash and cash equivalents has changed by +$40.31 M (+83.14%)